Clinical news & media

14/11/2022 - Press releases

Medimaps Group announces partnership with OsteoSys to bring trabecular bone score to Korea’s leading bone densitometry platform

04/03/2022 - Press releases

Medical reimbursement now available for trabecular bone score (TBS), an advanced medtech solution with artificial intelligence capabilities, for osteoporosis fracture risk assessment

01/01/2021 - Press releases

Medimaps Group raises $20 million to expand and to commercialize AI product portfolio for bone health assessment utilizing routine medical images

1 2

medimaps group SA
Chemin du Champ-des-Filles 36A
1228 Plan-les-Ouates
Geneva, Switzerland

Medimaps Group USA LLC
1201N Market Street
Suite 111
Wilmington, DE 19801, United States

Customer care

Medimaps Group has been certified by BSI to ISO 13485:2016 under certificate number MDR 799726. TBS iNsight is a trademark of Medimaps Group. TBS iNsight™ is cleared for sale in the U.S.